XML 25 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
2 Months Ended 7 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Feb. 28, 2017
Sep. 30, 2017
Sep. 30, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flow from operating activities:          
Net loss   $ 13,812 $ 15,334 $ (21,068)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation, depletion and amortization   48,393 62,017 68,478  
Amortization of debt issuance costs   926 4,042 1,988  
Impairment of long-lived asset       0  
Stock-based compensation expense   902 3,502 1,851  
Deferred income taxes   7,196 3,146 1,888  
Increase in allowance for doubtful accounts   970 (20) 970  
Gain on sale of assets and other, net   (20,687) 522 (22,930)  
Reorganization expenses, net   1,376 (24,199) 0  
Derivatives activities:          
Total (gains) losses   (5,642) 129,902 66,900  
Cash settlements   9,902 (47,161) 3,068  
Cash settlements on canceled derivatives   0 (126,949) 0  
Changes in assets and liabilities:          
Increase in accounts receivable   (3,095) (11,546) (7,022)  
(Increase) decrease in other assets   (11,397) (774) (13,175)  
Increase (decrease) in accounts payable and accrued expenses   11,416 5,574 6,619  
Increase (decrease) in other liabilities   16,433 (6,056) 19,832  
Net cash provided by (used in) operating activities   70,505 7,334 107,399  
Cash flow from investing activities:          
Development of oil and natural gas properties   (38,445) (74,447) (52,712)  
Purchases of other property and equipment   (11,497) (11,305) (12,767)  
Acquisition of properties   (259,444) 0 (249,338)  
Proceeds from sale of properties and equipment and other   234,823 3,377 234,292  
Net cash (used in) provided by investing activities   (74,563) (82,375) (80,525)  
Cash flow from financing activities:          
Proceeds from sale of Series A convertible preferred stock   0 0 0  
Repayments on credit facility       (451,000)  
Debt issuance costs   (22,049) (9,173) (22,170)  
IPO proceeds net of issuance costs   0 134,362    
Repurchase of common stock   0 (23,712)    
Payment to preferred stockholders in conversion   0 (60,273)    
Issuance of 2026 Senior Unsecured Notes   0 400,000    
Dividends paid on Series A preferred stock   0 (11,301)    
Purchase of treasury stock   0 (20,265)    
Shares withheld for payment of taxes on equity awards   0 (422)    
Net cash used in financing activities   (43,049) 30,216 (43,170)  
Net decrease in cash and cash equivalents   (47,107) (44,825) (16,296)  
Cash, cash equivalents and restricted cash:          
Beginning   85,034 68,738 85,034  
Ending $ 85,034 37,927 23,913 68,738  
Predecessor          
Cash flow from operating activities:          
Net loss (502,964)       $ (1,283,196)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation, depletion and amortization 28,149       178,223
Amortization of debt issuance costs 416       1,849
Impairment of long-lived asset 0       1,030,588
Stock-based compensation expense 0       0
Deferred income taxes 9       (11)
Increase in allowance for doubtful accounts 0       0
Gain on sale of assets and other, net (25)       (212)
Reorganization expenses, net 501,872       43,289
Derivatives activities:          
Total (gains) losses (12,886)       20,386
Cash settlements 534       8,007
Cash settlements on canceled derivatives 0       1,701
Changes in assets and liabilities:          
Increase in accounts receivable (9,152)       (6,556)
(Increase) decrease in other assets (2,842)       1,962
Increase (decrease) in accounts payable and accrued expenses 18,330       22,101
Increase (decrease) in other liabilities 990       (4,934)
Net cash provided by (used in) operating activities 22,431       13,197
Cash flow from investing activities:          
Development of oil and natural gas properties (859)       (21,988)
Purchases of other property and equipment (2,299)       (12,808)
Acquisition of properties 0       0
Proceeds from sale of properties and equipment and other 25       194
Net cash (used in) provided by investing activities (3,133)       (34,602)
Cash flow from financing activities:          
Proceeds from sale of Series A convertible preferred stock 335,000       0
Repayments on credit facility (497,668)       (1,701)
Debt issuance costs 0       0
IPO proceeds net of issuance costs 0        
Repurchase of common stock 0        
Payment to preferred stockholders in conversion 0        
Issuance of 2026 Senior Unsecured Notes 0        
Dividends paid on Series A preferred stock 0        
Purchase of treasury stock 0        
Shares withheld for payment of taxes on equity awards 0        
Net cash used in financing activities (162,668)       (1,701)
Net decrease in cash and cash equivalents (143,370)       (23,106)
Cash, cash equivalents and restricted cash:          
Beginning 228,404 85,034   85,034 251,510
Ending 85,034       228,404
New Credit Facility          
Cash flow from financing activities:          
Borrowings under credit facility   390,800 197,210 402,285  
Repayments on credit facility   (11,800) (576,210) (23,285)  
New Credit Facility | Predecessor          
Cash flow from financing activities:          
Borrowings under credit facility 0       0
Repayments on credit facility 0       0
Emergence Credit Facility          
Cash flow from financing activities:          
Borrowings under credit facility   51,000 0 $ 51,000  
Repayments on credit facility   (451,000) 0    
Emergence Credit Facility | Predecessor          
Cash flow from financing activities:          
Borrowings under credit facility 0       $ 0
Repayments on credit facility 0        
Pre-Emergence Credit Facility          
Cash flow from financing activities:          
Repayments on credit facility   $ 0 $ 0    
Pre-Emergence Credit Facility | Predecessor          
Cash flow from financing activities:          
Repayments on credit facility $ (497,668)